Indmedica Home | About Indmedica | Medical Jobs | Advertise On Indmedica
Search Indmedica Web
Indmedica - India's premier medical portal

Biomedical Research

Banaba: The natural remedy as antidiabetic drug

Author(s): Cheolin Park and Jae-Sik Lee

Vol. 22, No. 2 (2011-04 - 2011-06)

Cheolin Park1 and Jae-Sik Lee2

(1) Wellness banaba Co. Ltd. 864-1 Janghang-dong, Ilsandong-gu, Goyang-si, Gyeonggi-do KOREA 410-380
(2)Department of Clinical Laboratory Science, Hyejeon College, San 16, Namjang-ri, Hongseong-eup, Hongseong-gun, Chungcheongnam-do Korea 350-702

Abstract

Banaba (Lagerstroemia speciosa Pers) leaves has been used as tea or decoction type in the Philippines for blood sugar control and used in the treatment of diabetes in India and con-tain a treterpenoid compound know as a corosolic acid which can promote the absorption and utilization of glucose in the cell by transporting the stimulated glucose. As such, banaba plays a role in regulating levels of blood sugar and insulin in the blood. Banaba might de-crease blood sugar but most of countries prefer to use diabetes medications even though they aware of serious side-effects. Additionally, various adverse effects are reported recently when many diabetic patients have been taken antidiabetic drugs in the long term. Here we reviewed whether banaba and corosolic acid can be replaced for current antidiabetic drugs through published several mechanisms of banaba and antidiabetic drugs, respectively. Con-sequently, banaba, one of medicinal herbs for antidiabetic effect surely can be functioned and can be a perfect candidate instead of antidiabetic drugs on lowering or maintaining normal blood sugar levels and prevention of diabetic complications without as well as treat-ment without any adverse effects.

Key words: Lagerstroemia speciosa diabetes blood glucose corosolic acid GLUT4 (glucose transporter)
Accepted December 17 2010

Introduction

Lagerstroemia speciosa Pers. (locally known as banaba in the Philippines) is widely distributed in most part of Phil-ippines, India and Malaysia. Banaba includes several compounds such as corosolic acid and tannins, including lagerstroemin that have effects on the treatment of diabe-tes. These ingredients are thought to stimulate glucose uptake and have insulin-like activity. The latter activity is thought to be secondary to activation of the insulin recep-tor tyrosine kinase [1] or the inhibition of tyrosine phos-phatase. That’s why banaba is called “natural plant insu-lin”.

The hot water leaves extract has reported to reduce dia-betic symptoms in genetically diabetic KK-AY mice [2]. For past several years, banaba has been reported that vari-ous active ingredients isolated from L. speciosa leaves shows their hypoglycemic properties through increase the rate of glucose uptake or inducing glucose transport like insulin [3]. Glucose uptake is mediated in muscle mainly by the insulin-regulated glucose transporter (GLUT4). In the absence of insulin, this transporter slowly recycles between an intracellular storage compartment and the plasma membrane [4,5].

Corosolic acid, one of primary components from banaba extract induced GLUT4 (Glucose Transporter) transloca-tion in diabetic mice [6]. The hypoglycemic effects from several human studies were shown with standard extract from L. speciosa leaves on 56 type II diabetic [7], with banaba tablet containing banaba extract on 24 mild type II diabetic patients [8], with banaba extract on 18 diabetic patients with one-year clinical study [9] and with coroso-lic acid on 31 subjects [10]. Unfortunately, many antidia-betic drugs are currently prescribing at hospitals and clin-ics over the world but recently various side effects were found and reported [11,12,13]. The alternative medicine from natural resource for diabetes or lowering of blood sugar level which has good efficacy without any side ef-fects should be necessary because diabetes actually need long-term period management. In this short review paper, we review and compare with the mechanism of antidia-betic drugs and published hypoglycemic effects and those mechanisms of banaba. Therefore, we strongly recom-mend to pre-and diabetic patients that prior to taking a dose of antidibectic drugs have lots of side effects, it is the most valuable way to find the treatment or preventive way to maintain a normal blood glucose level and to pre-vent diabetic complications from natural resources.

Mechanism of antidiabetic drugs

The primary antidiabetic prescribing drugs can be classi-fied in four groups: (a) drugs which indirectly increase insulin release; (b) drugs which activates directly insulin receptors; (c) drugs which act directly as inhibitors of glucosidase; (d) drugs which decreases the liver’s glucose output. There are also major four different classes of antidiabetic drugs depend on different mechanisms: sul-fonylureas, insulin-sensitizing agents, biguanides, and alpha-glucosidase inhibitors [14,15].

Sulfonylureas act by lowering blood sugar by stimulating the beta cells in the pancreas to release more insulin. Generally sulfonylureas are included Glucotrol (glipizide) and Amaryl (glimepiride) [16] but are reported various side effects such as hypoglycemia, upset stomach skin rash or itching and weight gain.

Insulin sensitizers function by improving the sensitivity to insulin and work with insulin to move sugar into the cells, directly targeting for insulin resistance. They lower the amount of sugar released by the liver and make fat cells more sensitive to the effects of insulin. Two major drugs of this class are included Actos (pioglitazone) and Avandia (rosiglitazone) [14,15]. Recently, Avandia looks to be prohibited from the EU market and heavily re-stricted here in the US and several Asian countries be-cause several studies were reported the serious problems on heart failure. Biguanides improve insulin’s ability to move sugar into cells especially into the muscle cells. A biguanide class is included Metformin (Glucophage) which also improves control of glycemia primarily by inhibiting hepatic gluco-neogenesis and glycogenolysis [17]. However, biguanides can cause very serious condition called lactic acidosis so this is primarily a concern in people with kidney problems or heart failure. Alpha-glucosidase inhibitors retard the digestion and ab-sorption of carbohydrates in the small intestine and hence reduce the increase in blood glucose level after meals. These drugs do not cause the pancreas to produce more insulin. However, side effects can be bloating, gas and diarrhea. Current prescribing drugs are Precose and Glyset [14,15].

Rosiglitazone (Avandia), pioglitazone (Actos) and met-formin (Glucophage) act by both reducing glucose pro-duction in the liver, and increasing insulin dependent glu-cose uptake in muscle cells [14,15,17].

Mechanisms of banaba extract and corosolic acid

The blood sugar-lowering activity of extracts prepared from the leaves of banaba has been demonstrated in a number of animal models and clinical studies, including normal rats fed high levels of soluble starch [18], alloxan-diabetic rats [19,20], male genetically obese-diabetic (KK-Ay) mice [2]. Hypoglycemic effects of banaba ex-tracts have also been shown in placebo-controlled clinical trials in subjects with type II diabetes [7] and mild type II diabetes [8]. Like antidiabetic drugs, several mechanisms of banaba and corosolic acid, one of components from banaba extracts on lowering blood glucose levels were elucidated [6].

(a) Glucose Transport Enhancers

Studies indicate that the majority of antidiabetic constitu-ents so far identified in banaba are glucose transport en-hancers [6,21,22]. These substances of great interest for their potential use as energy tonics for the elderly and as means to maintain healthy blood glucose [6]. The glucose transport-enhancing activity of banaba was previously shown in a group of ellagitannins in the leaves known as flosin B, lagerstroemin and reginin A [21,22]. Lager-stroemin produced dose-dependent glucose transport-activating activity from concentrations of 0.02 to 0.30mM [22], and in subsequent studies was shown to possess multiple insulin-like activities in vitro [21]. The results suggested that the “insulin-like” glucose transport-enhancing activity of “the ellagitannins or their metabo-lites” was responsible for the blood glucose-lowering ac-tivity of banaba reported in studies in diabetic patients [22].

(b) Insulin-Mimetic (peptide analogs) activity

More recently, it was shown that small molecule compo-nents of gallotannins, which along with ellagitannins are major components of tannic acid, not only hold dose-dependent glucose transport-stimulating activity in mouse pre-adiposcytes, but many of the insulin-mimetic activi-ties found from banaba as well. These small components were identified as alpha- and beta-pentagalloylglucose (α- and βPGG). However, of the two, the alpha form was clearly the more potent. α PGG also stimulated transloca-tion of GLUT4 [23], inhibited differentiation of pre-adipocytes, and targeted the insulin receptor, the latter helping to explain its various insulin-like activities.

(c) GLUT4 activation

GLUT4 is a protein in muscle and gat cells which trans-ports glucose across plasma membrane, thereby allowing cells to gain energy and to maintain healthy blood sugar levels. Physical exercise is widely known to help maintain healthy glucose metabolism [24,25] in large part because physical exercise enhances GLUT4 levels in muscles. Indeed, a long-term high-fat diet has the opposite of low-ering their levels [26] and whereas the increase in blood flow from exercise allows GLUT4 to move into muscle membranes [5,27].

Banaba and diabetes

(d) Alpha-Amylase and Alpha Glucosidase Inhibitors

One study found banaba tea inhibited α-amylase activity by 38% [26] and others have reported that methanol and water extracts of the leaves inhibit both α-amylase and α-glucosidase [18]. Both α-amylase and α-glucosidase are enzymes involved in the digestion of carbohydrates and allow the accompanying increase in blood glucose levels following a meal containing starches and sugars. By in-hibiting these enzymes, carbohydrate absorption is de-layed along with the increase in blood sugar.

Discussion

Diabetes is widely and seriously recognized as one of the leading causes of death and disability in the world. Diabe-tes often leads to blindness, heart and blood vessel disease, stroke, kidney failure, amputations, and nerve damage. Currently, several antidiabetic drugs have been prescribed for lowering blood sugar levels and for retarding further development. However, unfortunately, various adverse effects such as heart failure, hypoglycemia, kidney failure and weight gain are reported. After all, FDA recently warned those side effects and prohibited selling of Avan-dia in the US. Due to various reported side effects, many scientists have been seeking for the substitution as antidiabetic drugs from the nature which have a hypogly-cemic effect [28]. Prior to the administration of nutraceu-ticals for antidibetes, however, it is necessary to under-stand their mechanism to be functioned correctly, compar-ing with that of current antidiabetic drugs.

All sulfonylurea drugs may cause hypoglycemia. Most patients become resistant to these drugs over time, and may require either dose adjustments or a switch to insulin [14,15,16]. The administration of oral hypoglycemic drugs has been associated with increased cardiovascular mortality as compared with treatment with diet alone or diet plus insulin.

Alpha-glucosidase inhibitors are generally well tolerated, and do not cause hypoglycemia [14,15]. The most com-mon adverse effects are gastrointestinal problems, includ-ing flatulence, diarrhea, and abdominal pain.

Metformin causes gastrointestinal (stomach and digestive) reactions in about a third of patients. A rare, but very seri-ous, reaction to metformin is lactic acidosis, which occurs in patients with multiple medical problems, including re-nal insufficiency [17].

Thiazolidinediones [17] are generally well tolerated in early trials, but they are structurally related to an earlier drug, troglitazone, which was associated with liver func-tion problems. Research showed that after one to 16 months of therapy with pioglitazone or rosiglitazone, some patients developed serious edema and signs of con-gestive heart failure [11,13]. Due to various adverse ef-fects from these antidiabetic drugs, most of researchers have been found the active component for diabetes from natural resources [28,29,30]. Among several plants, the most strong candidate was banaba and corosolic acid as ingredients. When we investigate each mechanism of antidiabetic drugs, several same mechanisms can meet with those of banaba leaf extracts.

Oral administration of corosolic acid (10 mg/kg) to male genetically type 2 diabetic (KK-Ay) mice produced a de-crease in blood glucose levels which reached statistical significance only at 4 hours post-administration [6]. The antidiabetic activity of an extract from the leaves of Lagerstroemia speciosa has been demonstrated in a ran-domized clinical trial at daily dosages of 32 and 48mg (1% corosolic acid) for 2 weeks showed a significant re-duction in the blood glucose levels [7].

If we look several mechanisms of banaba and corosolic acid closely, there are same mechanism with that of antidibetic drugs. One of isolated six pentacyclic triter-penes from banaba leaves, corosolic acid was shown the best bioactivity against alpha-glucosidase, contributes most to the alpha-glucosidase inhibitory activity [31] and banaba tea inhibited α-amylase activity by 38% [26]. With these results, banaba and corosolic acid can be replaced with Precose and Glyset as alpha-amylase and alpha-glucose inhibitors.

Miura et al.[6] reported that corosolic acid induces GLUT4 translocation onto plasma membrane. Binding of insulin to receptors on muscle cells leads rapidly to fusion of those vesicles with the plasma membrane and insertion of the glucose transporters (GLUT4), thereby giving the cell an ability to efficiently take up glucose. Thereby, ba-naba and corosolic acid make the induction of GLUT4 translocation and uptake of glucose into the cells, lower-ing glucose levels in the blood. Furthermore corosolic acid stimulates glucose uptake via enhancing insulin re-ceptor phosphorylation [32]. This mechanism can be simi-larly functioned as pioglitazone (Actos) and rosiglitazone (Avandia) like insulin sensitizers were shown [14,15]. Fructose-2,6-bisphosphate (F-2,6-BP) plays a critical role in hepatic glucose output by regulating gluconeogenesis and glycolysis in the liver. Corosolic acid increased the production of F-2,6-BP along with a decrease in intracel-lular levels of cAMP both in the presence and in the ab-sence of forskolin in isolated hepatocytes. Corosolic acid inhibits gluconeogenesis by increasing the production of F-2,6-BP by lowering the cAMP level and inhibiting PKA activity in isolated hepatocytes [33]. These effects on he-patic glucose metabolism may underlie the various anti-diabetic actions of corosolic acid. Rosiglitazone (Avan-dia), pioglitazone (Actos) and metformin (Glucophage) were shown decreases hepatic glucose production so banaba and corosolic acid surely can be shown good effi-cacy instead of those current drugs [14,15,16].

Stimulation of insulin receptors is known to cause pho-phorylation of several proteins on tyrosine residues be-cause this event is an essential for insulin’s action on downstream signaling molecules. Hattori et al. [1] found that lagerstroemin induces tyrosine-phosphorylation of IRβ (insulin receptor). This can be proved that laber-stroemin, one of extract fractions from banaba can be antidibetic drugs such as Metformin which activates di-rectly insulin receptors.

Consequently, Banaba extract contains several bioactive components including corosolic acid and tannins, includ-ing lagerstroemin that act like insulin lowering the blood sugar in the body. Corosolic acid is a triterpenoid glyco-side that improves the cellular uptake of glucose and thought to stimulate glucose uptake and have insulin-like activity [3]. This component was observed to be an activa-tor of glucose transport into cells, which ultimately results in a lowering blood glucose levels. The latter activity is thought to be secondary to activation of the insulin recep-tor tyrosine kinase or the inhibition of tyrosine phos-phatase. Transporting glucose into cells is critical for pro-viding the energy necessary for those cells to carry out their vital functions.

With many published data, banaba and its extracts could be functioned on lowering or maintaining blood sugar levels with different mechanism. Banaba extracts may play a role in the treatment of diabetes, by affecting fac-tors (such as blood glucose level) that are associated with the development of diabetes. It also significantly in-creased insulin sensitivity and GLUT4 translocation, im-proved hyperglycemia, lowered hepatic lipid contents and triglycerides. It also acts as alpha-glucosidase inhibitors, slowing down the absorption of starchy foods from the intestine, thereby retarding the rise in blood glucose after meals [34].

Unfortunately, there are no direct applications to evaluate the mechanism of banaba extract on human subjects, which can be limited to confirm the mechanism. However, there are several human studies with banaba extract [7,8,9,10], which were shown the hypoglycemic effects and safety for a short and long-term period. It is impossi-ble to speculate the correct effective mechanism in the human body but the banaba extract surely could be func-tioned on lowering blood sugar level without adverse ef-fects. Those functions and mechanisms of banaba extracts mean that banaba will be the best natural antidiabetic remedy for prevention and treatment of diabetes as natural gift without any other side-effects shown in current pre-scribed antidiabetic drugs. Therefore, banaba will be very promising candidate for future antidiabetic drug market as ingredients or themselves.

Acknowledgments

Authors would like to thank to Mr. Cheol-Hoe Kim, CEO of Wellness banaba Co. Ltd., Korea and Mr. Futoshi Ma-tsuyama, CEO of Use Techno Corporation, Japan about their precious comment and advice on banaba.

References

  1. Hattori K, Sukenobu N, Sasaki T, Takasuga S, Hayashi T, Kasai R, Yamasaki K, Hazeki O. Activation of insu-lin receptors by lagerstroemin. J Pharmacol Sci 2003; 93, 69-73.
  2. Kakuda T, Sakane I, Takihara T, Ozaki Y, Takeuchi H, Kuroyanagi M. Hypoglycemic effect of extracts from Lagerstroemia speciosa L. leaves in genetically dia-betic KK-AY mice. Biosci Biotechnol Biochem 1996; 60, 204-208.
  3. Liu F, Kim J, Li Y, Liu X, Li J, Chen X. An extract of Lagerstroemia speciosa L. has insulin-like glucose up-take-stimulatory and adipocyte differentiation-inhibitory activities in 3T3-L1 cells. J Nutr 2001; 131, 2242-2247.
  4. Watson RT, Pessin JE. Bridging the GAP between in-sulin signaling and GLUT4 translocation. Trends Bio-chem Sci 2006; 31, 215-222.
  5. Zorzano A, Palacin M, Guma A. Mechanisms regulat-ing GLUT4 glucose transporter expression and glucose transport in skeletal muscle. Acta Physiol Scand 183, 43-58.
  6. Miura T, Itoh Y, Kaneko T, Ueda N, Ishida T, Fuku-shima M, Matsuyama F, Seino Y (2004) Corosolic acid induces GLUT4 translocation in genetically type 2 dia-betic mice. Biol Pharm Bull 27, 1103-1105.
  7. Judy WV, Hari SP, Stogsdill WW, Judy JS, Naguib YMA, Passwater R (2003) Antidiabetic activity of a standardized extract (Glucosol™) from Lagerstroemia speciosa leaves in type II diabetics: A dose-dependence study. J Ethnopharmacol 87, 115-117.
  8. Ikeda Y, Chen JT, Matsuda T (1999) Effectiveness and safety of banabamin tablet containing extract from ba-naba in patients with mild type 2 diabetes. Japan Pharmacol Ther 27, 829-835. (Japanese)
  9. Ikeda Y, Noguchi M, Kishi S, Masuda K, Kusumoto A, Zeida M, Abe K, and Kiso Y (2002) Blood glucose controlling effects and safety on single and long-term administration on the extract of Banaba leaves. J. Nutr Food 5, 41-53. (Japanese)
  10. Fukushima M, Matsuyama F, Ueda N, Egawa K, Takemoto J, Kajimoto Y, Yonaha N, Miura T, Kaneko T, Nishi Y, Mitsui R, Fujita Y, Yamada Y, Seino Y (2006) Effect of corosolic acid on postchallenge plasma glucose levels. Diabetes Res Clin Pract 73, 174-177.
  11. Ozkaya O, Yavuz O, Can B, Dilek M, Savli E, Acikgoz Y, Bedir A, Akpolat T (2010) Effect of rosiglitazone on cisplatin-induced nephrotoxicity. Ren Fail 32, 368-371.
  12. Ng JM, Mellor DD, Masson EA, Allan BJ (2010) Sul-phonyurea as a cause of severe hypoglycaemia in the community. Prim Care Diabetes 4, 61-63.
  13. Shah P, Mudaliar S (2010) Pioglitazone: side effect and safety profile. Expert Opin Drug Saf 9, 347-54.
  14. Phillips PJ, Twigg SM (2010) Oral hypoglycaemics – a review of the evidence. Aust Fam Physician 39, 651-653.
  15. Sundaram A, Anand Moses CR, Ilango S, Seshiah V (1998) Newer Antidiabetic drugs. Int. J. Diab. Dev. Countries 18, 24-30.
  16. Proks P, Reimann F, Green N, Gribble F, Ashcroft F (2002) Sulfonylurea stimulation of insulin secretion. Diabetes 51, S368-376.
  17. Bailey CJ (2002) Treating insulin resistance in type 2 diabetes with metformin and thiazolidinediones. Diabe-tes Obes Metab 7, 675-691.
  18. Suzuki Y, Hayashi K, Sakane I, Kakuda T (2001) Effect and mode of action of banaba (Lagerstroemia speciosa L) leaf extracts on postprandial blood glucose in rats. J Japan Soc Nutr Food Sci 54, 131-137.
  19. Mishra Y, Khan MSY, Zafar R, Agarwal SS (1990) Hypoglycemic activity of leaves of Lagerstroemia spe-ciosa L Pers. Indian J Pharmacol 22, 174-176.
  20. Miyaji N, Kazama M, Ina H, Yamada K, Yamakawa T (1999) Influence of banaba-kuwa extracted powder on plasma glucose level in rat. J Trad Med 16, 208-211.
  21. Murakami C, Myoga K, Kasai R, Ohtani K, Kurokawa T, Ishibashi S, Dayrit F, Padolina WG, Yamasaki K (1993) Screening of plant constituents for effect on glucose transport activity in Ehrlich ascites tumour cells. Chem Pharm Bull 41, 2129-2131.
  22. Hayashi T, Maruyama H, Kasai R, Hattori K, Takasuga S, Hazeki O, Yamasaki K, Tanaka T (2002) Ellagitan-nins from Laegerstromia speciosa as activators of glu-cose transport in fat cells. Planta Med 68, 173-175.
  23. Li Y, Kim J, Li J, Liu F, Liu X, Himmeldirk K, Ren Y, Wagner TE, Chen X (2005) Natural anti-diabetic comp-ound 1,2,3,4,6-penta-O-galloyl-D-glucopyranose binds to insulin receptor and activates insulin-mediated glu-cose transport signaling pathway. Biochem Biophys Res Commun 336, 430-437.
  24. Holten MK, Zacho M, Gaster M, Juel C, Wojtaszewski JF, Dela F (2004) Strength training increases insulin-mediated glucose uptake, GLUT4 content, and insulin signaling in skeletal muscle in patients with type 2 dia-betes. Diabetes 53, 294-305.
  25. Short KR, Vittone JL, Bigelow ML, Proctor DN, Rizza RA, Coenen-Schimke JM, Nair KS (2003) Impact of aerobic exercise training on age-related changes in in-sulin sensitivity and muscle oxidative capacity. Diabe-tes 52, 1888-1896.
  26. Hansawasdi C, Kawabata J, Kasai T. α-Amylase in-hibitors from roselle (Hibiscus sabdariffa Linn.) tea. Biosci Biotechnol Biochem 2000; 64: 1041-1043.
  27. Wasserman DH, Ayala JE (2005) Interaction of physio-logical mechanisms in control of muscle glucose up-take. Clin Exp Pharmacol Physiol 32, 319-323.
  28. Nahas R and Moher M. (2009) Complementary and alternative medicine for the treatment of type 2 diabetes. Can Fam Physician. 55, 591-596.
  29. Malviya N, Jain S, Malviya S (2010) Antidiabetic po-tential of medicinal plants. Acta Pol Pharm 67, 113-118.
  30. Samad A, Shams MS, Ullah Z, Wais M, Nazish I, Sul-tana Y, Aqil M (2009) Status of herbal medicines in the treatment of diabetes: a review. Curr Diabetes Rev 5, 102-111.
  31. Toda M, Kawabata J, Kasai T (2001) Inhibitory effects of ellagi- and gallotannins on rat intestinal α-glucosidase complexes. Biosci Biotechnol Biochem 65, 542-547.
  32. Shi L, Zhang W, Zhou YY, Zhang YN, Li JY, Hu LH, Li J (2008) Corosolic acid stimulates glucose uptake via enhancing insulin receptor phosphorylation. Eur J Pharmacol 584, 21-29.
  33. Yamada K, Hosokawa M, Fujimoto S, Fujiwara H, Fu-jita Y, Harada N, Yamada C, Fukushima M, Ueda N, Kaneko T, Matsuyama F, Yamada Y, Seino Y, Inagaki N (2008) Effect of corosolic acid on gluconeogenesis in rat liver. Diabetes Res Clin Pract 80, 48-55.
  34. Hou W, Li Y, Zhang Q, Wei X, Peng A, Chen L, Wei Y (2009) Triterpene acids isolated from Lagerstroemia speciosa leaves as alpha-glucosidase inhibitors. Phyto-ther Res 23, 614-618.

Correspondence to:
Cheolin Park

Wellness Banaba Co. Ltd.
864-1 Janghang-dong, Ilsandong-gu, Goyang-si
Gyeonggi-do, Korea 410-380

Access free medical resources from Wiley-Blackwell now!

About Indmedica - Conditions of Usage - Advertise On Indmedica - Contact Us

Copyright © 2005 Indmedica